| DRAVPa1741 |
Sequence 9 from Patent US 7476649 B2 |
Sos scrofus(pig) |
Infuenza Virus,Vaccinia Virus,HIV |
US 7476649 B2 |
| DRAVPa1742 |
Sequence 10 from Patent US 7476649 B2 |
Sos scrofus(pig) |
Infuenza Virus,Vaccinia Virus,HIV |
US 7476649 B2 |
| DRAVPa1743 |
Sequence 11 from Patent US 7476649 B2 |
Sos scrofus(pig) |
Infuenza Virus,Vaccinia Virus,HIV |
US 7476649 B2 |
| DRAVPa1744 |
Sequence 12 from Patent US 7476649 B2 |
Sos scrofus(pig) |
Infuenza Virus,Vaccinia Virus,HIV |
US 7476649 B2 |
| DRAVPa1745 |
P9 |
Synthetic construct |
SARS-CoV-2 |
US20230165936 A1 |
| DRAVPa1746 |
P9R |
Synthetic construct |
SARS-CoV-2 |
US20230165936 A1 |
| DRAVPa1747 |
PS19 |
Synthetic construct |
ASFV |
US 8592552 B2 |
| DRAVPa1748 |
RS27 |
Synthetic construct |
ASFV |
US 8592552 B2 |
| DRAVPa1749 |
SS20 |
Synthetic construct |
ASFV |
US 8592552 B2 |
| DRAVPa1750 |
RS28 |
Synthetic construct |
ASFV |
US 8592552 B2 |
| DRAVPa1751 |
COVA1 |
Synthetic construct |
ASFV |
US 8592552 B2 |
| DRAVPa1752 |
PEP1 |
Synthetic construct |
ASFV |
US 8592552 B2 |
| DRAVPa1753 |
Sequence 1 from Patent US20090233868 A1 |
Human La protein |
HCV |
US20090233868 A1 |
| DRAVPa1754 |
Sequence 2 from Patent US20090233868 A1 |
Human La protein |
HCV |
US20090233868 A1 |
| DRAVPa1755 |
Sequence 10 from Patent CN104072579 B |
Synthetic construct |
HIV |
CN104072579 B |
| DRAVPa1756 |
Sequence 2 from Patent CN104072579 B |
Synthetic construct |
HIV |
CN104072579 B |
| DRAVPa1757 |
Sequence 13 from Patent CN104072579 B |
Synthetic construct |
H5N1 |
CN104072579 B |
| DRAVPa1758 |
Sequence 12 from Patent CN104072579 B |
Synthetic construct |
H5N1 |
CN104072579 B |
| DRAVPa1759 |
Sequence 1 from Patent US20110135676 B2 |
Synthetic construct |
AIV |
US20110135676 B2 |
| DRAVPa1760 |
Sequence 2 from Patent US20110135676 B2 |
Synthetic construct |
AIV |
US20110135676 B2 |